• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • Pilot Plan of the UDI System in Hainan Launched

Pilot Plan of the UDI System in Hainan Launched

Thursday, 03 December 2020 / Published in Medical Device, NMPA Registration in China

Pilot Plan of the UDI System in Hainan Launched

Following the launch of the China’s national UDI system, the Hainan Medical Products Administration (MPA) announced (No.114-2020) the commencement of their pilot plan for the UDI system in Hainan on November 27, 2020.

China’s National UDI System

From January 1, 2021 onwards, all companies with medical devices listed in the first batch are officially required to submit the product identification (DI) in the registration management system for:

  • First registrations
  • Renewal registrations
  • Product change applications

The UDI code must be labelled for products manufactured on or from January 1, 2021 onwards. Watch NMPA’s short introductory video about their online UDI database.

Hainan’s UDI System (Pilot Plan)

In addition to the first batch of medical devices required by China’s national UDI system, Hainan’s UDI system plans to cover 18 types of high-risk class III medical devices (announced in No.9 – 2020 by the China National Health Commission last year on January 14), and 11 specified types of class II and III medical devices (announced in No.114-2020 by the Hainan MPA).

The Hainan MPA addressed the following targets to be achieved:

November – December 2020

  • Establish a working group
  • Make suggestions and preparation for the layout work of the UDI system
  • Organize training and practice
  • The Hainan MPA should keep the NMPA updated on the implementation progress of the pilot plan
  • Applicants in Hainan whose products are mentioned on the specified list of class III medical devices shall submit the DI by the end of December 2020

April 2021

  • Hold an internal meeting to follow up on the implementation progress and review the common issues

December 2021

  • Applicants in Hainan whose products are mentioned on the specified list of class II medical devices shall submit the DI by the end of December 2021
  • The implementation of the UDI system in Hainan shall be completed by the end of December 2021 for sharing information about the registration approvals, clinical data, medicare settlement, etc. online

The following participants are expected to be involved in the pilot plan:

  • The Hainan MPA
  • The Hainan National Health Commission (NHC)
  • The National Healthcare Security Administration of Hainan
  • Hainan class II and III applicants
  • Specified business enterprises and public medical institutes above the B grade
  • The Pharmaceutical Profession Association
  • UDI code agencies

By Jacky Li. Contact Cisema if you would like to learn more.

Tagged under: hainan, UDI

What you can read next

China medical device registration electronic certificates
China medical device registration electronic certificates – Full implementation
NMPA Annual Report
NMPA Publishes 6 Regulatory Drafts Concerning Clinical Trials for Medical Devices and IVDs

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • China medical device sampling inspection results

    China medical device sampling inspection results no.4 of 2022

    China medical device sampling inspection result...
  • NMPA cosmetic sampling inspection

    The NMPA Cosmetic Sampling Inspection measures come into force on March 1, 2023

    NMPA Cosmetic Sampling Inspection Measures come...
  • China cosmetics quality safety responsibilities

    China cosmetics quality and safety responsibilities regulations released

    China cosmetics quality and safety responsibili...
  • China cosmetics efficacy claims FAQ

    China cosmetics efficacy claims FAQ available to answer key questions

    China cosmetics efficacy claims FAQ is availabl...
  • China cosmetics GMP inspections

    China cosmetics GMP inspections points have been finalised

    China cosmetics GMP inspections points and judg...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP
Cookies on Cisema
Learn more about Cisema's Privacy Policy.